Abstract:Objective: microRNAs (miRNAs) are regulatory RNAs that act as important players in diverse biologic and pathologic processes. Under circumstance as podocye-injury triggering proteinuria, which miRNAs are up-regulated or down-regulated? This experiment aims at detecting miRNAs changes in PAN nephrosis rats based on miRNA arrays and exploring the therapeutic targets of Leizhi capsule. Methods: Fifty male wistar rats were randomly divided into five groups, including control group, model group, leizhi capsule group, Tripterygium glucosides group, and valsartan group. PAN nephrosis models were made by jugular vein injection of PAN (100 mg/kg body weight, dissolve in physiological saline), while control group rats were made by jugular vein injection of physiological saline with equal volume. Other groups rats had been given medicines by irrigating stomach once a day for ten days. Blood and urine samples were collected, and renal tissues were processed after rats being euthanasised. The 24 h urinary protein excretion and blood biochemistry parameters were measured by routine methods. The glomerular morphology and podocyte ultrastructure were observed with light microscopy and transmission electron microscopy respectively. miRNA expression profile was detected by Exiqon miRNA Array. Real time RT-PCR analysis for mature miRNAs was used to validate differentially expressed miRNAs. Results: 1) In day 3 - 5, model rats had decreased urine volume, ascites, malnutrition and wight loss. From day 7 to day 10, the nephrotic syndromes were worst in model rats, but which had no skin edema. Some rats died in serious ascites, the mortality is 3/10. 2) miRNA array detection shows 106 miRNAs up regulated and 62 miRNAs down regulated in PAN nephrosis rats. Fold change (model vs. control group) varies from 1.8 to 7.0. For leizhi capsule group and model sample, there are 90 miRNAs differentially expressed, with 65 miRNAs up and 25 miRNAs down. The most important finding in our research is the discovery of the specific miRNAs related to PAN nephrosis (rno-miR23a, rno-miR-24, rno-miR-30c and rno-miR-300-3p), which have been validated by Real time RT-PCR analysis. 3) Compared with control sample, immune fluorescence intensity of dicer, expression profile of nephrin, podocin and synaptopodin mRNA and protein decrease in PAN nephrosis rats. After treated with Leizhi Capsule, immune fluorescence intensity of the above molecules improved. Conclusion: 1) Characteristic miRNAs of PAN nephrosis were screening. Up-regulated miRNAs (rno-miR-23a, rno-miR-300-3p) may trigger podocyte injury and proteinuria, while down-regulated miRNAs (rno-miR-24, rno-miR-30c) may be protective factors by anti-apoptosis. 2) Dicer and these miRNAs (rno-miR-24, rno-miR-30c, rno-miR-23a) may be are probably key molecules therapeutic targets of Leizhi capsule.

Expression and Distribution of Podocin in Rats Model of Minimal Change Disease

Podocin expression in rats with puromycin aminonucleoside nephropathy

Expression of Podocalyxin in Rats with Puromycin Aminonucleoside Nephropathy

Nephrin Expression in Rat Model of Minimal Change Nephrology

Correlation between urinary protein excretion and morphometric changes of glomerular foot process in rats with puromycin aminonucleoside nephropathy

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Expression Changes and Significance of Podocin of Podocytes during the Ischemia-Reperfusion in Rat Kidney

Key Molecular Events in Puromycin Aminonucleoside Nephrosis Rats

Protective effect of SRT1720 on podocyte injury in rats with experimental nephropathy

Podocyte Apoptosis is Suppressed by 1,25(OH)2D3 in Puromycin Aminonudeoside Nephropathy Rats

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

Relationship Between Podocyte Molecule's Distribution and Expression, Foot Process Morphology and Proteinuria

Mirnas Expression and Role of Dicer on Podocyte Injury in PAN Nephrosis Rats

Down-regulation of Nestin Expression in the Glomeruli with Foot Process Effacement and Its Correlation with the Degree of Proteinuria

Establishment of a podocyte cell injury model induced by puromycin aminonucleoside

Increased Expression of Podocyte Molecules Might Cause Proteinuria in Adriamycin-Induced Nephrotic Rats

Optimization and Evaluation of Puromycin Aaminonucleoside Nephropathy Model in Rats

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats with Puromycin Aminonucleoside Nephrosis.

[New Insight in Pathogenesis of Podocyte Disfunction in Minimal Change Disease].

Alteration of Podocyte Protein Expression and Localization in the Early Stage of Various Hemodynamic Conditions

Therapeutic effect of triptolide on podocyte injury in nephrosis rats induced by puromycin aminonucleoside